Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Gains (Losses) on Sale of Assets & Investments (2025)

Updated

Abeona Therapeutics' Gains (Losses) on Sale of Assets & Investments came in at $152.37 million for FY2025.

Analysis

Abeona Therapeutics (ABEO) Gains (Losses) on Sale of Assets & Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 152.37 Mn
API Access

Abeona Therapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ABEO&period=max&api_key=YOUR_API_KEY